Literature DB >> 7759201

Postoperative cytology in relation to recurrences of superficial bladder tumours.

M Hanus1, M Matouskova, H Smolova.   

Abstract

TNM classification allows only a partial estimation of future tumour behaviour after surgery. More knowledge on malignant potential is needed. Spreading of viable tumour cells during transurethral resection (TUR) and their possible subsequent implantation in the bladder mucosa should be an important factor influencing duration of the tumour-free interval (TFI). A total of 1384 fresh urine samples sequentially taken after surgery from 356 patients were examined in a cytological laboratory. Data analysis confirmed significant differences in TFI between the groups with negative, suspicious and positive cytology. The higher the cytological abnormalities the shorter was TFI, regardless of which histopathological tumour grade has been verified.

Entities:  

Mesh:

Year:  1994        PMID: 7759201     DOI: 10.1007/BF02767720

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  19 in total

Review 1.  [False positive urinary cytology. Diagnostic and prognostic value in the detection and surveillance of urothelial tumors. Apropos of 57 false positive cases in a series of 1000 cytologies].

Authors:  A Gilloz; J L Laurent; D Reymondon-Lachaud; P Héritier; J P Favre; E el Hajj; J Diez Yanguas
Journal:  J Urol (Paris)       Date:  1989

Review 2.  Precursor lesions of invasive bladder cancer.

Authors:  L G Koss
Journal:  Eur Urol       Date:  1988       Impact factor: 20.096

3.  Blood group antigen expression in urothelial neoplasia.

Authors:  C Limas
Journal:  Eur Urol       Date:  1988       Impact factor: 20.096

4.  Correlation of histopathological, cytological and flow cytometric findings in neoplastic and nonneoplastic lesions of the bladder.

Authors:  D F Cowan; B Wu; G P Young; O P Khanna
Journal:  J Urol       Date:  1987-10       Impact factor: 7.450

5.  Detection of ABH antigens via exfoliated urinary cells. A preliminary report.

Authors:  H Tsujihashi; S Uejima; T Akiyama; T Kurita
Journal:  Urol Int       Date:  1987       Impact factor: 2.089

Review 6.  Recurrent or aggressive bladder cancer. Indications for adjuvant intravesical therapy.

Authors:  R A Badalament; V Ortolano; J K Burgers
Journal:  Urol Clin North Am       Date:  1992-08       Impact factor: 2.241

7.  Chromosomal and DNA patterns in transitional cell bladder carcinoma. A comparative cytogenetic and flow-cytofluorometric DNA study.

Authors:  H Wijkström; I Granberg-Ohman; B Tribukait
Journal:  Cancer       Date:  1984-04-15       Impact factor: 6.860

8.  Positive urinary cytology after tumor resection: an indicator for concomitant carcinoma in situ.

Authors:  N Harving; H Wolf; F Melsen
Journal:  J Urol       Date:  1988-09       Impact factor: 7.450

9.  [Value of microhematuria, urine cytology, TPA and neopterin in the after care of patients with bladder tumors].

Authors:  D Mack; K Scheiber; H Rauschmeier; L Hamberger; G Jakse
Journal:  Urol Int       Date:  1987       Impact factor: 2.089

10.  HLA-DR expression by high grade superficial bladder cancer treated with BCG.

Authors:  S Prescott; K James; A Busuttil; T B Hargreave; G D Chisholm; J F Smyth
Journal:  Br J Urol       Date:  1989-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.